This announcement is a separate document:
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
19:31
证监会发布《监管规则适用指引——机构类第4号》，为进一步强化证券基金经营机构董事长、总经理的专业胜任能力,拟任董事长、总经理应当从事证券、基金或者金融工作3年以上,且至少1人具备3年以上与拟任职务相关的证券、基金工作经历。该要求适用于本指引发布后拟任董事长、总经理的人员。
19:31
The Securities Regulatory Commission issued a notice for the "full circulation" filing of Yaokai Ankang's overseas issuance and listing and the unlisted shares in the domestic market.
19:30
Novo-Nordisk A/S spokesperson: Complete results of Cagrisema will be announced at next year's medical conference. We plan to optimize dosage adjustments and further explore Cagrisem as an additional weight loss potential, with plans to start a new trial in the first half of 2025.
NVO-2.38%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.